CYP3A4 and herpes zoster: We therefore undertook a study in a large primary care clinical database in order to assess the risk of herpes zoster in relation to use of ICS in a general population of adults and to evaluate whether this risk is increased by the concomitant use of ICS and drugs which inhibit CYP3A4, the enzyme responsible for the hepatic inactivation of corticosteroids.